Acumen Pharmaceuticals (ABOS)

• Market cap: $202M
• 1 day: 2.14%
• 5 days: 6.03%
• 1 month: 36.33%
• 3 months: 59.05%
• 6 months: 171.54%
• Year to date: 65.35%
• 1 year: 160.94%
• 5 years: -83.38%
• 10 years: -83.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Employees: 52